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Accepted 21 June 2013AbstractObjective: We describe a prenatal molecular diagnosis of hypochondroplasia (HCH) in a pregnancy not at risk of HCH and review the literature
on prenatal diagnosis of HCH.
Case report: A 28-year-old primigravidwomanwas referred for genetic counseling at 30weeks of gestation because of short-limbed dwarfism in the
fetus. Thewoman had a body height of 152 cm. Her husband had a body height of 180 cm. Level II ultrasound showed a normal amount of amniotic
fluid and a singleton fetuswith fetal biometry equivalent to 30weeks except for short limbs. Fetal biometrymeasurementswere as follows: biparietal
diameter¼ 7.38 cm (30 weeks); head circumference¼ 28.14 cm (30 weeks); abdominal circumference (AC)¼ 24.64 cm (30 weeks); femur length
(FL) ¼ 3.97 cm (<5th centile); FL/AC ratio ¼ 0.161 (normal > 0.18); humerus ¼ 3.64 cm (<5th centile); radius ¼ 3.49 cm (30 weeks);
ulna ¼ 3.76 cm (<5th centile); tibia ¼ 3.67 cm (<5th centile); and fibula ¼ 3.72 cm (<5th centile). The digits and craniofacial appearance were
normal. A tentative diagnosis of achondroplasia (ACH)wasmade. DNA testing for theFGFR3 gene andwhole-genome array comparative genomic
hybridization (aCGH) analysis were performed using cord blood DNA obtained by cordocentesis. FGFR3 mutation analysis revealed a de novo
heterozygous c.833A>G, TAC> TGC transversion in exon 7 leading to a p.Tyr278Cys (Y278C) mutation in the FGFR3 protein. aCGH analysis
revealed no genomic imbalance in cord blood. After delivery, the fetus had short limbs, a narrow thorax, brachydactyly, and relative macrocephaly.
Cytogenetic analysis of cultured placental cells revealed a karyotype of 46,XX.
Conclusion: Prenatal diagnosis of abnormal ultrasound findings suspicious of ACH should include a differential diagnosis of HCH by molecular
analysis of FGFR3.
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Fig. 1. FGFR3 mutation analysis for cord blood and parental blood samples
revealed a de novo heterozygous c.833A > G, TAG > TGC transversion in
exon 7 leading to p.Tyr278Cys (Y278C) mutation in FGFR3 in the fetus.
Fig. 2. Whole-body X-ray of the fetus at birth.
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Hypochondroplasia (HCH; OMIM 146000) is an autosomal
dominant skeletal dysplasia caused by mutations in the
FGFR3 gene. FGFR3 (OMIM 134934) encodes fibroblast
growth factor receptor 3 and is located at 4p16.3. A hetero-
zygous FGFR3 N540K mutation accounts for 70% of all re-
ported patients [1,2]. HCH is characterized by short-limbed
dwarfism, broad short hands and feet, mild joint laxity, mac-
rocephaly, and roentgenographic findings of narrow inferior
lumbar interpedicular distances, short long bones with mild
metaphyseal flare, a short broad femur neck, and short square
ilia [3]. Prenatal molecular diagnosis of HCH in a pregnancy
not at risk of HCH is uncommon. Here, we present our
experience of prenatal diagnosis of a de novo FGFR3 Y278C
mutation in a pregnancy with fetal severe HCH and review the
literature on prenatal diagnosis of HCH.
Case report
A 28-year-old primigravid woman was referred for genetic
counseling at 30 weeks of gestation because of short-limbed
dwarfism in the fetus. The woman had a body height of
152 cm. Her husband was 30 years old and had a body height of
180 cm. Both were healthy and unrelated, and there was no
family history of congenital malformations. The prenatal ul-
trasound was unremarkable until 28 weeks of gestation, when a
short femur was noted, with a femur length (FL) of 3.9 cm
equivalent to 24 weeks. The biparietal diameter (BPD) was
7.3 cm (28 weeks), abdominal circumference (AC) was 23.7 cm
(28 weeks), and the FL/AC ratio was 0.165. Level II ultrasound
at 30 weeks of gestation showed a normal amount of amniotic
fluid and a singleton fetus with fetal biometry equivalent to 30
weeks except for short limbs. Fetal biometry measurements
were as follows (30-week 5the95th centile range):
BPD ¼ 7.38 cm (7.30e8.20 cm); head circumference
(HC) ¼ 28.14 cm (26.6e30.9 cm); AC ¼ 24.64 cm
(21.7e27.4 cm); FL¼ 3.97 cm (5.20e6.20 cm); HC/AC¼ 1.14
(0.97e1.18); HC/FL ¼ 7.09 (4.54e5.38); FL/AC ¼ 0.161
(normal > 0.18); humerus ¼ 3.64 cm (4.4e5.6 cm);
radius ¼ 3.49 cm (3.4e4.9 cm); ulna ¼ 3.76 cm (3.8e5.4 cm);
tibia ¼ 3.67 cm (4.1e5.6 cm); and fibula ¼ 3.72 cm
(3.8e5.2 cm). The digits and craniofacial appearance were
normal. A tentative diagnosis of achondroplasia (ACH) was
made. DNA testing for the FGFR3 gene and whole-genome
array comparative genomic hybridization (aCGH) analysis
were performed using cord blood DNA obtained by cordo-
centesis. FGFR3 mutation analysis revealed a de novo hetero-
zygous c.833A>G, TAC>TGC transversion in exon 7 leading
to a p.Tyr278Cys (Y278C) mutation in the FGFR3 protein
(Fig. 1). Mutation analysis of parental blood samples did not
reveal this mutation (Fig. 1). aCGH analysis revealed no
genomic imbalance in cord blood. A 1586-g fetus was delivered
at 31 weeks of gestation with a body length of 41 cm. The fetus
had short limbs, a narrow thorax, brachydactyly, and relative
macrocephaly (Fig. 2). Cytogenetic analysis of cultured
placental cells revealed a karyotype of 46,XX.
Table 1
Reported cases of hypochondroplasia with prenatal diagnosis.
Authors FGFR3 mutation Inheritance Prenatal findings Postnatal findings
Stoll et al [19] NA Familial
(paternal)
Father 28 y, 134 cm, HCH; mother: 28 y, 160 cm Delivery at 25 wk; X-ray: short
square iliac wings, reduced
sacroiliac notch, flat acetabular
roof with a spicule
Ultrasound (22 wk): FL ¼ 3.4 cm (e2.4 SD)
Jones et al [20] NA Sporadic Father 35 y, mother 35 y, both normal Delivery at 40 wk; X-ray: mildly
short femora and humeri, slight
narrowing of the sacroiliac notch;
X-ray (12 m): narrowing of the
interpediculate distances within the
lumbar spine, flattening of the
acetabular roofs, shortening of
proximal and distal long bones,
flattening of the base of the skull,
HCH
Ultrasound (26 wk): BPD ¼ 6.5 cm (26e27 wk),
FL ¼ 3.8 cm (24 wk), HL ¼ 3.9 cm (24 wk)
Ultrasound (35 wk): BPD ¼ 8.7 cm (35 wk),
FL ¼ 5.4 cm (27e28 wk), HL ¼ 4.7 cm (27e28 wk)
Ultrasound (39 wk): BPD ¼ 9.62 cm (39.3 wk),
AC ¼ 33.8 cm (37.7 wk), FL ¼ 5.89 cm (31.1 wk),
HL ¼ 5.44 cm (31.5 wk), FL/AC ¼ 0.174
Chitayat et al [21] p.G380R p.N540K Familial
(biparental)
Father 20 y, HCH, N540K; mother 25 y, ACH,
G380R
Delivery at 38 wk, 3325 g, high
forehead, large skull, frontal
bossing, depressed nasal bridge,
narrow chest, trident position of the
fingers, rhizomelic shortening of
long bones with flare of the
metaphyses, seizures and
hypotonia at 9d; CT scan at 2 wk:
partial agenesis of corpus
callosum, cerebral dysplasia
Amniocentesis (16 wk): compound heterozygous
FGFR3 G380R and N540K mutations
Ultrasound (14 wk 6 d): BPD ¼ 3.3 cm (15.6 wk),
FL ¼ 1.8 cm (15.1 wk), HL ¼ 1.6 cm (14.4 wk),
FL/AC ¼ 0.186
Ultrasound (17 wk 6 d): BPD ¼ 4.2 cm (18.4 wk),
FL ¼ 2.4 cm (17.4 wk), HL ¼ 2.3 cm (17 wk),
FL/AC ¼ 0.189
Ultrasound (22 wk 1 d): BPD ¼ 5.8 cm (23.6 wk),
FL ¼ 3.3 cm (20.2 wk), HL ¼ 3 cm (20.2 wk),
FL/AC ¼ 0.167
Ultrasound (27 wk 3 d): BPD ¼ 8 cm (32.2 wk),
FL ¼ 4.1 cm (23.2 wk), HL ¼ ¼ 3.6 cm (22.3 wk),
FL/AC ¼ 0.158
Ultrasound (31 wk 4 d): BPD ¼ 9.1 cm (37.3 wk),
FL ¼ 3.9 cm (22.4 wk), HL ¼ 3.7 cm (23 wk),
FL/AC ¼ 0.134
Huggins et al [22] p.N540K Familial
(paternal)
Father HCH, N540K; mother 23 y, ACH, G380R Delivery at 35 wk, 2706 g,
rhizomelic shortening of all limbs,
hypospadias; X-ray: short femora
and humeri; cord blood and
paternal blood: FGFR3 N540K
mutation; maternal blood: FGFR3
G380R mutation
Ultrasound (15 wk 6 d): BPD ¼ 3.8 cm (17.4 wk),
FL ¼ 1.8 cm (15.1 wk), HL ¼ 1.8 cm (15 wk),
AC ¼ 10.9 cm (16.4 wk), FL/AC ¼ 0.165
Ultrasound (18 wk 6 d): BPD ¼ 4.7 cm (20.2 wk),
FL ¼ 2.6 cm (17.6 wk), HL ¼ 2.6 cm (17.7 wk),
AC ¼ 14.7 cm (19.7 wk), FL/AC ¼ 0.177
Ultrasound (21 wk 6 d): BPD ¼ 5.6 cm (23.2 wk),
FL ¼ 3.2 cm (19.6 wk), HL ¼ 3.2 cm (20 wk),
AC ¼ 18.7 cm (23.3 wk), FL/AC ¼ 0.171
Ultrasound (24 wk 6 d): BPD ¼ 6.7 cm (27.2 wk),
FL ¼ 3.8 cm (21.8 wk), AC ¼ 21.9 cm (26.2 wk),
FL/AC ¼ 0.174
Ultrasound (28 wk 5 d): BPD ¼ 7.6 cm (30.8 wk),
FL ¼ 4.4 cm (24.1 wk), HL ¼ 4.0 cm (23.7 wk),
AC ¼ 26.3 cm (30.4 wk), FL/AC ¼ 0.167
Ultrasound (31 wk 1 d): BPD ¼ 8.6 cm (34.8 wk),
FL ¼ 4.3 cm (23.7 wk), AC ¼ 29.5 cm (33.6 wk),
FL/AC ¼ 0.146
Kataoka et al [23] c.1659C>G Sporadic Father 22 y, 170 cm; mother 23 y, 165 cm Delivery at 39 wk, 3000 g, mild
short limbs; X-ray: narrow thorax,
shortening of the greater sciatic
notches of the ilia, lack of normal
iliac flaring, oval radiolucent areas
of the proximal femora; cord
blood: 46,XY, FGFR3
c.1659C > G (de novo) mutation
Ultrasound (37 wk): FL ¼ 5.0 cm (28 wk),
BPD ¼ 9.15 cm (39 wk), FL/AC ¼ 0.18
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Table 1 (continued )
Authors FGFR3 mutation Inheritance Prenatal findings Postnatal findings
Bonnefoy et al [24] p.N540K Sporadic Father 35 y; mother 34 y Delivery at 38 wk; X-ray: narrow
thorax, lack of normal iliac flaring,
oval radiolucent areas of the
proximal femora
Ultrasound (12 wk & 22 wk): normal
Ultrasound (32 wk): FL ¼ 5.3 cm (28 wk),
HL ¼ 4.7 cm (28 wk)
Ultrasound (35 wk): FL ¼ 5.7 cm (30 wk),
HL ¼ 5.0 cm (30 wk), BPD ¼ 9.8 cm (40 wk),
FL/foot ¼ 0.81
3D ultrasound: lack of normal iliac flaring, depressed
nasal bridge, femoral metaphyseal abnormalities,
horizontalization of the roof of the cotyla,
radiolucent areas of the proximal femora
Amniocentesis (36 wk): 46,XX, FGFR3 N540K
(de novo) mutation
Karadimas et al [25]
Case 1 p.N540K Sporadic Father 35 y; mother 27 y, both average height Delivery at 27 wk, 1020 g, short
stature, bowed lower limbs, mildly
stubby hands and feet, normal
craniofacial appearance
Ultrasound (21 wk 2 d): normal
Ultrasound (23 wk 4 d): all long bones <5th centile,
FL/foot <0.87, FL/AC ¼ 0.18, ventriculomegaly,
bowing femora and humeri
Amniocentesis: 46,XY, exclusion of FGFR3 G380R
for ACH
Decreased long bone development at 27 wk
Retrospective study of prenatal DNA: FGFR3
N540K (de novo) mutation
Case 2 p.N540K Sporadic Father 33 y, mother 28 y, both average height Delivery at 28 wk, 1280 g, short
stature, bowed lower limbs, mildly
stubby hands and feet,
brachydactyly, normal cranium and
face, borderline increase in HC
Ultrasound (22 wk 2 d): all long bones 5the10th
centile
Ultrasound (24 wk 6 d): mild bowing of femora and
humeri (<5th centile), FL/foot <0.87, FL/AC <0.18
Amniocentesis: 46,XX, exclusion of FGFR3 G380R
for ACH
Ultrasound (28 wk): normal BPD, AC, foot length,
FL ¼ 4.3 cm (<3rd centile), HL ¼ 4.2 cm (<3rd
centile), FL/foot ¼ 0.74, FL/AC ¼ 0.17
Retrospective study of prenatal DNA: FGFR3
N540K (de novo) mutation
Hatzaki et al [26] p.N540K Familial
(maternal)
Mother 31 y, HCH TOP
CVS (12 wk): FGFR3 N540K mutation
Park et al [27]
Two cases p.N540K Familial
(maternal)
Mother <27 y, HCH, N540K TOP in two pregnancies
CVS: FGFR3 N540K mutation in two pregnancies
Wang et al [12] p.G342C Familial
(maternal)
Father 170 cm; mother 25 y, 131 cm, HCH Delivery at 29 wk; X-ray: HCH;
cord blood and maternal blood:
FGFR3 G342C mutation
Ultrasound (13 wk): normal
Ultrasound (23 wk): FL ¼ 3.43 cm (20 wk 6 d),
FL/foot ¼ 0.8, FL/AC ¼ 0.18, BPD normal
Ultrasound (28 wk): FL ¼ 4.6 cm (25 wk), BPD
normal
Present case p.Y278C Sporadic Father 30 y, 180 cm; mother 28 y, 152 cm Delivery at 31 wk, 1586 g; X-ray:
short limbs, brachydactyly, relative
macrocephaly
Ultrasound (13 wk, 16 wk, & 24 wk): normal
Ultrasound (28 wk): BPD ¼ 7.3 cm (28 wk),
FL ¼ 3.9 cm (24 wk), AC ¼ 23.7 cm (28 wk),
FL/AC ¼ 0.165
Ultrasound (30 wk): BPD ¼ 7.38 cm (30 wk),
FL ¼ 3.97 cm (<5th centile), AC ¼ 24.64 cm
(30 wk), FL/AC ¼ 0.161
Cordocentesis: FGFR3 Y278C (de novo) mutation
AC ¼ abdominal circumference; ACH ¼ achondroplasia; BPD ¼ biparietal diameter; CVS ¼ chorionic villus sampling; FL ¼ femur length; HC ¼ head
circumference; HCH ¼ hypochondroplasia; HL ¼ humerus length; NA ¼ not available; SD ¼ standard deviation; TOP ¼ termination of pregnancy.
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The present case was associated with a de novo heterozy-
gous Y278C mutation in FGFR3 and HCH. The patient carried
a single base substitution (c.833A > G, TAC > TGC) thatsubstitutes tyrosine 278 with cysteine (Y278C) in the first half
of the third immunoglobulin-like loop of FGFR3. Approxi-
mately 70% of patients affected with HCH have a heterozy-
gous mutation in FGFR3, andw72% of patients with FGFR3
mutations have N540K (Asn540Lys) resulting from FGFR3
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Other rare mutations include S84L [9], R200C [9], N262H [9],
G268C [9], Y278C [9], L324V [10], N328I [11], G342C [12],
V381E [9], I538V [13], N540S [14,15], N540T [16], K650N
[17], K650Q [9,18], and K652Q [17]. In a study of 74 patients
with HCH, Heuertz et al found 10 (14%) familial cases and 64
(86%) sporadic cases with the following mutations: N540K
(63.5%; 47 cases), K650Q (1.4%; 1 case), N328I (1.4%; 1
case); novel mutations of S84L, R200C, N262H, G268C,
Y278C and V381E (8%; 6 cases); and no FGFR3 mutation
(25.7%; 19 cases) [9]. Heuertz et al first reported a Y278C
FGFR3 mutation in a patient with severe HCH [9]. The patient
had a phenotype of ACH at birth, manifest as rhizomelic
dwarfism, macrocephaly with midface hypoplasia, thor-
acolumbar kyphosis, short trident hands, and mild hypotonia at
the age of 6 months; and a phenotype of HCH with normal
craniofacial features, small stature with relatively short upper
arms and thighs, and lumbar hyperlordosis at the age of 3.5
years.
To date, at least 12 cases of HCH with prenatal diagnosis
have been reported [12,19e27]. Table 1 lists the FGFR3 mu-
tations and prenatal and postnatal findings for 13 cases of HCH
with prenatal diagnosis, including the present case. Among the
13 cases, six were sporadic and seven were familial, of which
three involved paternal HCH [19,21,22] and four involved
maternal HCH [12,26,27]. Five cases were carried to term de-
livery [20e24]. In the two cases with ACH and HCH in either
parent, the parents decided to continue with the pregnancy even
though prenatal ultrasound and/or molecular genetic analysis
confirmed familial inherited skeletal dysplasia [21,22]. The data
in Table 1 show that fetuses with HCH can present with a short
femur and humerus, relative macrocephaly, and an FL/AC ratio
<0.18 in late second trimester without the associated abnor-
malities of ventriculomegaly, congenital heart defects, poly-
dactyly, narrow thorax, and polyhydramnios. Prenatal findings
for HCH are very similar to those for ACH. Therefore, prenatal
diagnosis of abnormal ultrasound findings suspicious of ACH
should include a differential diagnosis of HCH by molecular
analysis of FGFR3 G380R and N540Kmutations and other rare
FGFR3 mutations associated with ACH and HCH if necessary.
In the present case, the mother had a short stature but no mo-
lecular evidence of HCH. Prenatal diagnosis of short-limbed
dwarfism in the presence of parental short stature other than
ACH should raise a suspicion of familial HCH. For instance,
Stoll et al reported prenatal diagnosis of paternally inherited
HCH with a paternal height of 134 cm [19] and Wang et al re-
ported prenatal diagnosis of maternally inherited HCH with a
maternal height of 131 cm [12]. Prenatal diagnosis of HCH can
be achieved by molecular analysis of fetal DNA extracted from
amniotic fluid cells [19,24,25], chorionic villi cells [26,27], cord
blood lymphocytes (present case), or single-cell analysis by
blastomere biopsy [27]. Park et al reported on a successful
pregnancy and birth with preimplantation genetic diagnosis
using single-cell PCR and sequencing in a 27-year-old woman
with HCH, FGFR3 N540K mutation, and two consecutive
abortions of HCH-affected fetuses diagnosed by molecular
sequencing of chorionic villus samples [27].In summary, we have described prenatal molecular diag-
nosis of a de novo Y278C FGFR3 mutation in a pregnancy
with fetal severe HCH and reviewed the literature on prenatal
diagnosis of HCH. We emphasize the importance of molecular
analysis of the FGFR3 gene in prenatally detected short-
limbed dwarfism suspicious of ACH and HCH.References
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